Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL440641 | 0.92 | ALDH1A1 (0.52) | ALDH1A1TSHR | |
| SCHEMBL28362672 | 0.84 | ALDH1A1 (0.47) | ALDH1A1TSHR | |
| SCHEMBL27647336 | 0.82 | ALDH1A1 (1.00) | ALDH1A1TSHRCYP2C9KDM4EMAPT | |
| SCHEMBL29445 | 0.82 | — | — | |
| SCHEMBL4888140 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRCYP2C9 | |
| SCHEMBL9403053 | 0.81 | ALDH1A1 (0.76) | ALDH1A1TSHRCYP2C9KDM4EMAPT | |
| SCHEMBL2675454 | 0.80 | ALDH1A1 (0.49) | ALDH1A1TSHR | |
| Acetonitrile SCHEMBL23070461 | 0.78 | ALDH1A1 (0.92) | ALDH1A1TSHRCYP2C9KDM4EMAPT | |
| SCHEMBL4885635 | 0.78 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL20472549 | 0.77 | TSHR (0.46) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11292760-B2 | Therapeutic acrylates as enhanced medical adhesives | CARNEGIE MELLON UNIVERSITY (US) | 2022-04-05 | — | — | US | disclosed |
| US-20190262497-A1 | Therapeutic Acrylates as Enhanced Medical Adhesives | CARNEGIE MELLON UNIVERSITY | 2019-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11292760-B2 | Therapeutic acrylates as enhanced medical adhesives | ILK, COL2A1, BMP2 | ALDH1A1 1019/4885TSHR 4756/4885CYP2C9 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.